FDA’s Preparedness For Nanotech Debated At Public Meeting
This article was originally published in The Gray Sheet
Executive Summary
A former FDA deputy commissioner joined other speakers at an Oct. 10 meeting in urging the agency to seek additional expertise and resources in its oversight of products that rely on materials controllable at scales as small as one-billionth of a meter
You may also be interested in...
FDA Prepares To Issue Regulatory Guidance For Nanotechnology Devices
FDA should develop guidance for products that use nanotechnology and take steps to address the risks and benefits of the emerging technology, a July 25 agency task force report recommends
FDA Prepares To Issue Regulatory Guidance For Nanotechnology Devices
FDA should develop guidance for products that use nanotechnology and take steps to address the risks and benefits of the emerging technology, a July 25 agency task force report recommends
Former HHS Chiefs Lead Fight For Bigger FDA Budget
Three former HHS secretaries joined industry, consumer and patient advocacy groups Sept. 25 to launch an early effort to increase appropriations for FDA in fiscal year 2008